Informing humanitarians worldwide 24/7 — a service provided by UN OCHA

World + 16 more

Pacific syndromic surveillance report: Week 13 ending 3 April 2016

Attachments

The following syndromes have been flagged:

· Acute Fever and Rash: Fiji

· Diarrhoea: American Samoa,Fiji, Northern Mariana Islands,

· Influenza-like Illness: French Polynesia, Guam, New Caledonia

· Prolonged fever: Fiji, Vanuatu

Other updates:

Zika virus

· Fiji: There have been an additional 10 RT-PCR confirmed cases out of 100 serum samples sent to the Institute of Environmental Science and Research laboratory (ESR), New Zealand. There have been 15 confirmed cases in total, two were in 2015 and the remainder this year. Source: Fiji Ministry of Health & Medical Services.

· Zika cases have been reported in 2016 in American Samoa, Tonga, Kosrae state, Federated States of Micronesia, Samoa, and Marshall Islands.

Chikungunya

· One imported case with travel history to Fiji reported by ESR, New Zealand for the period 26/03/2016 – 01/04/2016.

Conjunctivitis

· Increasing number of cases reported continue to be reported particularly from the capital city, Suva,** Fiji.** Source: Fiji Ministry of Health & Medical Services

Dengue

· French Polynesia: there were 33 confirmed cases, including 3 hospitalisations for week ending 27 March 2016. Dengue serotype 1 is in circulation. The weekly number of cases is decreasing. Source: French Polynesia Ministry of Health.

Influenza

· French Polynesia: Increase in Influenza cases reported for week ending 27 March 2016. Nineteen (46 %) of 41 samples collected were Influenza A positive and include 6 A (H3N2); 4 A (H1N1)pdm09 pandemic and 9 non-typeable. Of these confirmed cases, there were 17 hospitalisations including a new born and a child less than 16 years of age. Source: French Polynesia Ministry of Health.

Ebola Virus Disease (EVD)

· There has been a new case of EVD in Liberia in a 30 year old woman who died. This latest marks the third flare-up since the outbreak was declared over 9 May 2015. The WHO has reiterated that additional flare-ups are expected in the months to come, largely due to the persistence of the virus in some survivors.